IST-3 Bibliography

311 views

Published on

0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total views
311
On SlideShare
0
From Embeds
0
Number of Embeds
2
Actions
Shares
0
Downloads
2
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

IST-3 Bibliography

  1. 1. Papers in peer-reviewed journals 1. Innes K. Thrombolysis for acute ischaemic stroke: core nursing requirements. British Journal of Nursing 2003;12(7):416-24 2. Kane I, Lindley R, Lewis S, Sandercock P. Impact of stroke syndrome and stroke severity on the process of consent in the Third International Stroke Trial. Cerebrovascular Diseases 2006;21:348-52 3. Whiteley W, Lindley R, Wardlaw J, Sandercock P. Third International Stroke Trial.. International Journal of Stroke. 2006;1:172-6 4. Sandercock P, Lindley R, Wardlaw J, Protocol 06PRT/1269: Third International Stroke Trial (IST-3). http://www.thelancet.com/journals/lancet/misc/protocol/06PRT-1269. 2006. 5. Wardlaw JM, Bath P, Sandercock P, Perry D, Palmer J, Watson G, Lloyd S, Geddes J, Farrall A. The NeuroGrid stroke exemplar clinical trial protocol.. International Journal of Stroke. 2007;2:63-9 6. The third international stroke trial (IST-3) of thrombolysis for acute ischaemic stroke. Sandercock P, Lindley R, Wardlaw J, Dennis M, Lewis S, Venables G, Kobayashi A, Czlonkowska A, Berge E, Bruins Slot K, Murray V, Peeters A, Hankey G, Matz K, Brainin M, Ricci S, Celani MG, Righetti E, Cantisani T, Gubitz G, Phillips S, Arauz A, Prasad K, Correia M, Lyrer P; the IST-3 collaborative group. Trials 2008 Jun 17;9(1):37. http://www.trialsjournal.com/content/9/1/37 7. SCOPE (Stroke Complications and Outcomes Prediction Engine) Collaborations and IST. Predicting outcome in hyper-acute stroke: validation of a prognostic model in the Third International Stroke Trial (IST3).. Journal of Neurology Neurosurgery and Psychiatry 2008;79:397-400 8. EPITHET-where next? Sandercock P, Wardlaw J, Dennis M, Lindley R, Hankey G, Matz K, Peeters A, Phillips S, Gubitz G, Prasad K, Ricci S, Celani MG, Righetti E, Cantisani T, Arauz A, Berge E, Slot KB, Kobayashi A, Czlonkowska A, Correia M, Murray V, Lyrer P, Venables G; IST-3 Collaborative Group. Lancet Neurology 2008 Jul;7(7):570-1; author reply 571-3. 9. Oxfordshire community stroke project clinical stroke syndrome and appearances of tissue and vascular lesions on pre-treatment CT in hyper-acute ischemic stroke among the first 510 patients in the Third International Stroke Trial (IST-3). Kobayashi A, Wardlaw J, Lindley R, Lewis S, Sandercock P, Czlonkowska A; IST-3 Collaborative Group. Stroke 2009 Mar;40(3):743-8. Epub 2009 Jan 8. Published abstracts [ (# number) = reference number in Cochrane Stroke Register] 1. Chang K-C. Thrombolysis for acute ischaemic stroke: The third international stroke trial (IST-3). [Abstract]. In: Proceedings of the 2003 Annual Meeting of Taiwan Stroke Society. 22-23 March 2003. Taiwan, Taipei: Taiwan Stroke Society. 2003:104. (# 6995) 2. Gubitz G, for the IST-3 Collaborative Group. The Third International Stroke Trial (IST-3) - Thrombolysis for acute ischemic stroke. [Abstract]. Journal of Stroke and Cerebrovascular Diseases 2000;9(4):208 (# 4959)
  2. 2. 3. Gubitz G, for the IST-3 Collaborative Group. The Third International Stroke Trial (IST-3) - Thrombolysis for acute ischemic stroke. [Abstract]. Canadian Journal of Neurological Sciences 2001;28 (Suppl 2):S28-9 (Abst.P-010) (# 5002) 4. Gubitz GJ, Lindley RI. Thrombolysis for Acute Ischaemic Stroke: the Third International Stroke Trial. [Abstract]. In: Proceedings of the 25th International Stroke Conference. 10-12 February 2000. USA, New Orleans, LA: American Stroke Association. 2000 (Abst. CTP253). (# 3357) 5. Hand P, Lindley R, Wardlaw J, Sandercock P. The Third International Stroke Trial (IST-3). [Abstract]. Stroke 2000;31(11):2866 (Abst.707) (# 4428) 6. Hand P, Lindley R, Wardlaw J, Sandercock P. Trials in progress: The Third International Stroke Trial (IST-3). [Abstract]. Stroke 2000;31(11):2886 (Abst.057) (# 4488) 7. Hand P, Lindley R, Wardlaw J, Sandercock P. The Third International Stroke Trial (IST-3). [Abstract]. Cerebrovascular Diseases 2001;11 (Suppl 4):35 (Abst.on_24) (# 4912) 8. Hand PJ, Lindley RI, Wardlaw JM, Sandercock PA. Thrombolysis for acute ischaemic stroke: the international stroke trial. [Abstract]. In: Proceedings of the 27th International Stroke Conference. Feb 7-9 2002. USA, San Antonio: The American Stroke Association. 2002 (Abst. CTP339). (# 5637) 9. Hand PJ, Lindley RI, Wardlaw JM, Sandercock PAG. Trials in progress: The third international stroke trial (IST-3). [Abstract]. Journal of the Neurological Sciences 2001;187(Suppl 1):S252 (Abst.P0723) (# 5495) 10. Hand PJ, Sandercock PA, Lindley RI, Wardlaw JM. Can intravenous rt-PA benefit a wider range of patients? The third international stroke trial (IST-3). [Abstract]. Cerebrovascular Diseases 2002;13(Suppl 3):80 (Abst.P347) (# 6138) 11. Hankey GJ, Hand PJ, Lindley RI, Wardlaw JM, Sandercock PA, Anderson C. Thrombolysis for acute ischaemic stroke: the third international stroke trial (IST-3). [Abstract]. In: Proceedings of the Stroke Society of Australasia 2001. 6-8 September 2001. New Zealand, Auckland: 2001:7 (Abst. S1.3). (# 5234) 12. Hankey GJ, Hand PJ, Lindley RI, Wardlaw JM, Sandercock PA, Anderson C. Thrombolysis for acute ischaemic stroke: The third international stroke trial (IST-3). [Abstract]. Journal of Clinical Neuroscience 2002;9(4):480 (Abst.S1-3) (# 7718) 13. Kane I, Lindley R, Sandercock P, Lewis S, on behalf of the IST-3 Collaborative Group. Consent for thrombolysis for acute ischaemic. stroke. [Abstract]. Cerebrovascular Diseases 2005;19 (Suppl 2):76 (Abst.15) (# 9291) 14. Kane I, Lindley R, Sandercock P. Consent for thrombolysis for acute ischaemic stroke.. [Abstract]. Age and Ageing 2005;34(Suppl 1):i37 (# 10906) 15. Kane I, Sandercock P, Lindley R, Gubitz G, Phillips S. The MRC Third International Stroke Trial (IST-3).. [Abstract]. In: Proceedings of the International Stroke Conference 2006. Ongoing Clinical Trials Abstracts. 16 February 2006. USA, Kissimmee, Florida: 2006 (Abst.CTP10). (# 10273)
  3. 3. 16. Kane I, Sandercock P, Lindley R, Lewis S, on behalf of the IST-3 Collaborative Group. The Third International Stroke Trial. Baseline characteristics of patients recruited in the expansion phase. [Abstract]. Cerebrovascular Diseases 2005;19 (Suppl 2):29 (Abst.2) (# 9300) 17. Kane I, Sandercock P, Lindley R, Lewis S. Third International Stroke Trial: characteristics of patients recruited in the start-up phase.[Abstract]. Stroke 2004;35(1):295 (Abst.P218) (# 7853) 18. Kane I, Sandercock P, Lindley R, Lewis S. The Third International Stroke Trial. Baseline characteristics of patients recruited in the expansion phase.. [Abstract]. Cerebrovascular Diseases 2004;17(Suppl 5):110 (Abst.30) (# 8260) 19. Kane I, Sandercock P, Lindley R, Lewis S. The Third International Stroke Trial. Baseline characteristics of patients recruited in the expansion phase. [Abstract]. Stroke 2004;35(6):e216 (# 8325) 20. Kane I, Sandercock P, Lindley R, Lewis S. The Third International Stroke Trial: baseline characteristics of patients recruited in the expansion phase. [Abstract]. Stroke 2005;36(2):450 (Abst.P65) (# 8904) 21. Kane I, Sandercock P, Lindley R, Lewis S. The Third International Stroke Trial (IST-3). Thrombolysis for acute ischaemic stroke: characteristics of patients randomised in the expansion phase.. [Abstract]. Age and Ageing 2005;34(Suppl 1):i45 (# 10907) 22. Kane I, Sandercock P, Lindley R. The Third International Stroke Trial (IST-3). [Abstract]. In: Proceedings of the 13th European Stroke Conference (http://www.eurostroke.org/esc_ongoing_trials.asp). 13-15 May 2004. Germany, Mannheim- Heidelberg: 2004 (Abst. 12). (# 8241) 23. Kane I, Sandercock P, Lindley R. The Third International Stroke Trial (IST-3). [Abstract]. Stroke 2004;35(6):e200 (# 8331) 24. Kane I, Sandercock P, Lindley R. Third International Stroke Trial. [Abstract]. In: Proceedings of the 29th International Stroke Conference. 5-7 February 2004. USA, San Diego, California: American Stroke Association. 2004 (Abst. CTP26). (# 8372) 25. Kane I, Sandercock P, Lindley R. Third International Stroke Trial. [Abstract]. In: Proceedings of the International Stroke Conference 2005. Ongoing Clinical Trials Abstracts. 2 February 2005. USA, New Orleans, Louisiana: American Stroke Association. 2005 (Abst. CTP29). (# 8865) 26. Kane I, Sandercock P, Lindley R. The Third International Stroke Trial (IST-3). [Abstract]. In: Proceedings of the 15th European Stroke Conference. 16-19 May 2006 2006. Belgium, Brussels: 2006 (Abst. 2). (# 10210) 27. Kane I, Sandercock P. Third International Stroke Trial (IST-3). Thrombolysis for acute ischaemic stroke. [Abstract]. Journal of Neurology Neurosurgery and Psychiatry 2004;75:797 (Abst.036) (# 9657) 28. Kane I, Sandercock P. The Third International Stroke Trial (IST-3). Thrombolysis for acute ischaemic stroke. [Abstract]. Journal of Neurology Neurosurgery and Psychiatry 2005;76(9):1314 (Abst.007) (# 9658)
  4. 4. 29. Kane I, Wardlaw J, Sandercock P, Lewis S, on behalf of the IST-3 Collaborative Group. Baseline CT characteristics of the first 253 patients in the Third International Stroke Trial. [Abstract]. In: Proceedings of the BASP: British Association of Stroke Physicians Annual Scientific Meeting. 19 January 2005. UK, Newcastle upon Tyne: British Association of Stroke Physicians. 2005:4. (# 8842) 30. Kobayashi A, Bembenek J, Sandercock P, Kane I, Skowronska M, Czlonkowska A, et al. Correlation of stroke subtype in OCSP classification and early ischaemic changes on CT: an analysis based on the first 389 patients from the IST-3 trial.. [Abstract]. Cerebrovascular Diseases 2006;21(Suppl 4):35 (Abst.15) (# 10556) 31. Kobayashi A, Sandercock P, Czlonkowska A, Lewis S, Wardlaw J. Early ischaemic changes on CT and the OCSP classification: an analysis of the first 389 patients from the IST-3 trial.. [Abstract]. European Journal of Neurology 2006;13(Suppl 2):26 (Abst.SC222) (# 11050) 32. Lewis SC, Sandercock PA, Lindley RI, Wardlaw JM, Dennis MS. The MRC Third International Stroke trial (IST-3).. [Abstract]. In: Proceedings of the 16th European Stroke Conference 2007. 29 May - 1 June 2007. UK, Glasgow: 2007. (# 11919) 33. Lindley R, Grimley R. The third international stroke trial (IST-3): thrombolysis for acute ischaemic stroke.. [Abstract]. Internal Medicine Journal 2007;37(Suppl 3):A84 (Abst.P29) (# 12275) 34. Lindley R, Hand P, Sandercock P, Wardlaw J, Lewis S, Warlow C, Dennis M. The Third International Stroke trial (IST-3). [Abstract]. 35. In: Proceedings of the 7th International Symposium on Thrombolysis and Acute Stroke Therapy. 27-28 MAY 2002. France, Lyon:2002:71. (# 6089) 36. Lindley R, Kobayashi A, Wardlaw J, Sandercock P, Lewis S. Persisting hyperdense artery sign, aspects score and risk of developing mass effect: analysis from the first 389 patients in IST-3.. [Abstract]. Internal Medicine Journal 2007;37(Suppl 1):A7 (# 12319) 37. Lindley R. IST-3: Thrombolysis for acute ischaemic stroke. Unpublished. (# 3614) 38. Lindley RI, Sandercock PAG, Wardlaw JM, Dennis MS, Lewis SC. Thrombolysis for stroke - what are the 'grey areas' of uncertainty and are they changing? results from the Third International Stroke Trial IST-3.. [Abstract]. Internal Medicine Journal 2008;38(Suppl 4):A96 (# 13642) 39. Lindley RI, Sandercock PAG, Wardlaw JM, Dennis MS, Lewis SC. Hyperintense artery sign, atrial fibrillation and infarct subtype in the Third International Stroke Trial IST-3.. [Abstract]. Internal Medicine Journal 2008;38(Suppl 4):A96 (# 13643) 40. Lindley RI. The third international stroke trial: thrombolysis for acute ischaemic stroke. [Abstract]. In: Proceedings of the 28th International Stroke Conference. February 13-15 2003. USA, Phoenix, Arizona: The American Stroke Association. 2003 (Abst. CTP22). (# 6840) 41. Lindley RI. The Third International Stroke Trial. Baseline characteristics of patients recruited.. [Abstract]. Internal Medicine Journal 2005;35(Suppl):A62 (# 12517)
  5. 5. 42. Maasland E, Kabboord A, Koudstaal PJ, Dippel DWJ. The effect of heparin on serum lipoprotein levels in patients with acute ischemic stroke or TIA. [Abstract]. Cerebrovascular Diseases 2002;13(Suppl 3):38 (Abst.P172) (# 6118) 43. Ricci S, Celani MG, Righetti E, Cantisani AT. Thrombolysis for ischaemic stroke: the IST 3 study.. [Abstract]. In: Proceedings of the Italian Stroke Forum - Stroke 2004. 7-9 March 2004 2004. Italy, Florence: 2004:158. (# 11649) 44. Ricci S, Celani MG, Righetti E, Cantisani TA. International Stroke Trial 3. Thrombolysis for acute ischaemic stroke.. [Abstract]. In: Proceedings of the Stroke 2003 National Stroke Conference. 2-4 March 2003. Italy, Florence: 2003. (# 10523) 45. Ricci S, Celani MG, Righetti E, Mazzoli T. Thrombolysis for acute ischaemic stroke: the IST 3 study.. [Abstract]. In: Proceedings of the Italian Stroke Forum - Stroke 2007. 15-16 February 2007 2007. Italy, Florence: 2007 (Abst. ACTER 02). (# 11653) 46. Sandercock P, Kane I, Lindley R, Lewis S, Dennis M, Wardlaw J. The MRC Third International Stroke Trial (IST-3): baseline characteristics of patients recruited in the expansion phase. [Abstract]. Journal of the Neurological Sciences 2005;238 (Suppl 1):S439 (Abst.1331) (# 9983) 47. Sandercock P, Kane I, Lindley R, Lewis S, Dennis M, Wardlaw J. Baseline CT characteristics of the first 317 patients in the MRC Third International Stroke Trial (IST-3). [Abstract]. Journal of the Neurological Sciences 2005;238 (Suppl 1):S439-40 (Abst.1332) (# 9984). 48. Sandercock P, Lindley R, Wardlaw J. The Third International Stroke Trial.. [Abstract]. In: Proceedings of the UK Stroke Forum Conference 2006. 7-8 December 2006. UK, Harrogate: The Stroke Association. 2006:59 (Abst. Poster 85). (# 11384) 49. Sandercock P, Lindley R. Third international stroke trial (IST 3). [Abstract]. In: Proceedings of the British Association of Stroke Physicians. 22nd January 2003. UK, Stoke on Trent: British Association of Stroke Physicians. 2003. (# 6709) 50. Sandercock P, Lindley R. The third international stroke trial (IST-3). [Abstract]. In: Proceedings of the 12th European Stroke Conference. 21-24 May 2003. Spain, Valencia: 2003 (Abst. 16). (# 6941) 51. Sandercock P, Murray V, Berge E, on behalf of the IST 3 Collaborative Group. Third International Stroke Trial (IST 3). [Abstract]. In: Proceedings of the 12th Nordic Meeting on Cerebrovascular Diseases. 17-20 September 2003. Norway, Oslo: 2003:26 (Abst. O-023). (# 7452) 52. Sandercock P. Can intravenous rt-PA benefit a wider range of patients? The third International Stroke Trial (IST-3). [Abstract]. In: Proceedings of the 7th International Symposium on Thrombolysis and Acute Stroke Therapy. 27-28 MAY 2002. France, Lyon: 2002:51. (# 6086) 53. Sandercock PA, Lindley R, Wardlaw J, Lewis S, Dennis M. The Third International Stroke Trial (IST-3).. [Abstract]. In: Proceedings of the 17th European Stroke Conference. 13-16 May 2008. France, Nice: 2008 (Abst. 4). (# 13243)
  6. 6. 54. Sandercock PA, Wardlaw J, Lindley R, Dennis M, Lewis S. Thrombolysis for stroke - what are the "grey areas" of uncertainty and are they changing? Results from the third international stroke trial (IST-3).. [Abstract]. Cerebrovascular Diseases 2008;25(Suppl 2):192 (Abst.3) (# 13579) 55. Sandercock PAG, Lindley RI, Wardlaw JM, Dennis MS, Lewis SC. The MRC Third International Stroke Trial (IST-3).. [Abstract]. In:Proceedings of the UK Stroke Forum Conference 2007. 4-6 December 2007. UK, Harrogate: The Stroke Association. 2007:69 (Abst.Poster 92). (# 12607) 56. Sandercock PAG, Lindley RI, Wardlaw JM, Dennis MS, Lewis SC. Thrombolysis for stroke - what are the "grey areas" of uncertainty and are they changing? Results from the Third International Stroke Trial (IST-3).. [Abstract]. In: Proceedings of the UK Stroke Forum Conference 2007. 4-6 December 2007. UK, Harrogate: The Stroke Association. 2007:71-2 (Abst. Poster 99). (# 12628) 57. Skowronska M, Bembenek J, Sandercock P, Kane I, Kobayashi A, Czlonkowska A, et al. Persisting hyperdense artery sign, aspects score and risk of developing mass effect: an analysis based on the first 389 patients from the IST-3 trial.. [Abstract]. Cerebrovascular Diseases 2006;21(Suppl 4):33-4 (Abst.8) (# 10557) 58. Venables G, Kane I, Sandercock P, Wardlaw J. Baseline CT characteristics of the first 137 patients in the start-up phase of the MRC Third International Stroke Trial (IST-3). [Abstract]. Journal of Neurology Neurosurgery and Psychiatry 2006;77:136 (Abst.055) (# 10159) 59. Whiteley W, Sandercock P, Lewis S, Wardlaw J, Venables G, Lindley R. The performance of UK centres in the Third International Stroke.Trial.. [Abstract]. In: Proceedings of the UK Stroke Forum Conference 2006. 7-8 December 2006. UK, Harrogate: The Stroke Association. 2006:57-8 (Abst. Poster 80). (# 11390) 60. Whiteley W, Sandercock P, Lindley R, Wardlaw J. CT appearances at baseline in the MRC Third International Stroke Trial: relationship with time from stoke onset to scan and stroke severity.. [Abstract]. Stroke 2007;38(2):488 (Abst.P10) (# 11487)

×